haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 21:50 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
  • 08 Aug 2024 17:36
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 25 Jul 2024 16:36
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 10 Jul 2024 11:29
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Update on disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 for Change in Director submitted on 05-07-2024'.

    PDF · -
  • 09 Jul 2024 16:59
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Appointment of Chairman'.

    PDF · -
  • 07 Jun 2024 17:03
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 03 Jun 2024 13:14
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Recommendation of appointment of Director '.

    PDF · -
  • 30 Apr 2024 18:13
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 30 Apr 2024 17:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 30 Apr 2024 17:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 29 Apr 2024 16:31
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Update on disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 submitted on 26-04-2024'.

    PDF · -
  • 26 Apr 2024 18:11
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 22 Mar 2024 13:58
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 07 Mar 2024 14:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 02 Feb 2024 14:27
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 13 Jan 2024 11:51
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 09 Jan 2024 17:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

    PDF · -
  • 25 Dec 2023 13:12
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 20 Dec 2023 19:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 20 Dec 2023 19:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 13 Nov 2023 17:01
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

    PDF · -
  • 07 Nov 2023 16:26
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 07 Nov 2023 15:46
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Amendment to the Employee Stock Option Scheme '.

    PDF · -
  • 26 Oct 2023 11:41
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.

    PDF · -
  • 23 Aug 2023 12:36
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA'.

    PDF · -
  • 08 Aug 2023 20:30
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 28 Jul 2023 19:29
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year 2022-23'.

    PDF · -
  • 12 Jun 2023 12:41
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s manufacturing facility T20 at Panoli, Gujarat'.

    PDF · -
  • 08 Jun 2023 12:05
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'General Update'.

    PDF · -
  • 26 May 2023 18:17
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 21 Dec 2022 17:45
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Updates on acquisition'.

    PDF · -
  • 14 Dec 2022 16:27
    General update

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 30 Nov 2022 14:17
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about ANDA approval received for Venlafaxine Hydrochloride Extended-Release Tablets from USFDA.

    PDF · -
  • 17 Nov 2022 19:52
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

    PDF · -
  • 11 Oct 2022 17:11
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

    PDF · -
  • 08 Sept 2022 13:22
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of 46th Annual General Meeting

    PDF · -
  • 12 Jul 2022 17:37
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

    PDF · -
  • 01 Jun 2022 14:28
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 28 Apr 2022 15:46
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 03 Nov 2021 14:20
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of status from promoter/promoter group to public'.

    PDF · -
  • 04 Oct 2021 12:38
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

    PDF · -
  • 17 Sept 2021 15:35
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Submission of application to the Stock Exchanges for re-classification of status from promoter/ promoter group to public'.

    PDF · -
  • 09 Sept 2021 18:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Appointment of Statutory Auditor'.

    PDF · -
  • 09 Sept 2021 18:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval by the shareholders of request for re-classification of status from promoter topublic of certain promoters/promoter group members'.

    PDF · -
  • 19 Aug 2021 15:03
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call transcript.'.

    PDF · -
  • 02 Aug 2021 14:44
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Result of Postal Ballot'.

    PDF · -
  • 29 Jul 2021 17:05
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

    PDF · -
  • 02 Jul 2021 17:16
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding '(1) Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (2) Disclosure under Code of practices and procedure for Disclosure of UPSI'.

    PDF · -
  • 02 Jul 2021 13:04
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Issue of Postal Ballot Notice'.

    PDF · -
  • 27 May 2021 12:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of receipt of requests from the promoters/ promoter group membersseeking re-classification of status as public'.

    PDF · -
  • 14 May 2021 15:45
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

    PDF · -
Older announcements →
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries